An early reduction in GH peak amplitude in preproghrelin-deficient male mice has a minor impact on linear growth

Endocrinology (United States)

Volumn 155, Issue 9, 2014, Pages 3561-3571

  Hassouna, Rim ^a   Zizzari, Philippe ^a   Tomasetto, Catherine ^c   Veldhuis, Johannes D ^d   Fiquet, Oriane ^a   Labarthe, Alexandra ^a   Cognet, Julie ^a   Steyn, Frederik ^b   Chen, Chen ^b   Epelbaum, Jacques ^a   Tolle, Virginie ^a  

^a INSERM   (France)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; GHRELIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PREPROGHRELIN; UNCLASSIFIED DRUG; PROTEIN PRECURSOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; GENOTYPE; GROWTH HORMONE RELEASE; GROWTH STIMULATION; HORMONE DEFICIENCY; MALE; MOUSE; NONHUMAN; PREPROGHRELIN DEFICIENCY; ULTRADIAN RHYTHM; ANIMAL; C57BL MOUSE; GENETICS; GROWTH, DEVELOPMENT AND AGING; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; GHRELIN; GROWTH HORMONE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN PRECURSORS;

EID: 84907056061     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1126     Document Type: Article

References (53)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656-660.
2. Tomasetto C, Karam SM, Ribieras S, et al. Identification and characterization of a novel gastric peptide hormone: the motilin-related peptide. Gastroenterology. 2000;119(2):395-405.
3. Tolle V, Zizzari P, Tomasetto C, Rio MC, Epelbaum J, Bluet-Pajot MT. In vivo and invitro effectsof ghrelin/motilin-related peptide on growth hormone secretion in the rat. Neuroendocrinology. 2001; 73(1):54-61.
4. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407(6806):908-913.
5. Gutierrez JA, Solenberg PJ, Perkins DR, et al. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA. 2008;105(17):6320-6325.
6. Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell. 2008;132(3):387-396.
7. Guan XM, Yu H, Palyha OC, et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res. 1997;48(1):23-29.
8. Katayama M, Nogami H, Nishiyama J, Kawase T, Kawamura K. Developmentallyand regionally regulated expressionofgrowthhor-mone secretagogue receptor mRNA in rat brain and pituitary gland. Neuroendocrinology. 2000;72(6):333-340.
9. Willesen MG, Kristensen P, Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology. 1999;70(5):306-316.
10. Tannenbaum GS, Lapointe M, Beaudet A, Howard AD. Expression of growth hormone secretagogue-receptors by growth hormone-releasing hormone neurons in the mediobasal hypothalamus. Endocrinology. 1998;139(10):4420-4423.
11. Nass R, Gaylinn BD, Thorner MO. The Role of ghrelin in GH secretion and GH disorders. Mol Cell Endocrinol (Elsevier Ireland Ltd). 2011;340:10-14.
12. Zizzari P, Halem H, Taylor J, et al. Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH Pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor. Endocrinology. 2005;146(9):3836-3842.
13. Sun Y, Ahmed S, Smith RG. Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol. 2003;23(22):7973-7981.
14. Sun Y, Wang P, Zheng H, Smith RG. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA. 2004; 101(13):4679-4684.
15. Wortley KE, Anderson KD, Garcia K, et al. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA. 2004;101(21):8227-8232.
16. Wortley KE, del Rincon J-P, Murray JD, et al. Absence of ghrelin protects against early-onset obesity. J Clin Invest. 2005;115(12): 3573-3578.
17. Sun Y, Butte NF, Garcia JM, Smith RG. Characterization of adult ghrelin and ghrelin receptor knockout mice under positive and negative energy balance. Endocrinology. 2008;149(2):843-850.
18. Ma X, Lin L, Qin G, et al. Ablations of ghrelin and ghrelin receptor exhibit differential metabolic phenotypes and thermogenic capacity during aging. PLoS One. 2011;6(1):e16391.
19. Tan HY, Huang L, Simmons D, Veldhuis JD, Steyn FJ, Chen C. Hypothalamic distribution of somatostatin mRNA expressing neurones relative to pubertal and adult changes in pulsatile growth hormone secretion in mice. J Neuroendocrinol. 2013;25(10):910-919.
20. Xu J, Gontier G, Chaker Z, Lacube P, Dupont J, Holzenberger M. Longevity effect of IGF-IR(+/-) mutation depends on genetic background-specific receptor activation. Aging Cell. 2014;13(1): 19-28.
21. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem. 1977;83(2): 346-356.
22. Steyn FJ, Huang L, Ngo ST, et al. Development of a method for the determination of pulsatile growth hormone secretion in mice. Endocrinology. 2011;152(8):3165-3171.
23. Feng DD, Yang SK, Loudes C, et al. Ghrelin and obestatin modulate growth hormone-releasing hormone release and synaptic inputs onto growth hormone-releasing hormone neurons. Eur J Neurosci. 2011;34(5):732-744.
24. Endo H, Yamaguchi M, Farnsworth R, et al. Mouse placental cells secrete immunoreactive growth hormone-releasing factor. Biol Re-prod. 1994;51(6):1206-1212.
25. Winsky-Sommerer R, Grouselle D, Rougeot C, et al. The proprotein convertase PC2 is involved in the maturation of prosomatostatin to somatostatin-14 but not in the somatostatin deficit in Alzheimer's disease. Neuroscience. 2003;122(2):437-447.
26. Keenan DM, Iranmanesh A, Veldhuis JD. Analytical construct of reversible desensitization of pituitary-testicular signaling: illustrative application in aging. Am J Physiol Regul Integr Comp Physiol. 2011;300(2):R349-R360.
27. Veldhuis JD, Johnson ML, Veldhuis OL, Straume M, Pincus SM. Impact of pulsatility on the ensemble orderliness (approximate entropy) of neurohormone secretion. Am J Physiol Regul Integr Comp Physiol. 2001;281(6):R1975-R1985.
28. Jansson JO, Albertsson-Wikland K, Eden S, Thorngren KG, Isaksson O. Effect of frequency of growth hormone administration on longitudinal bone growth and body weight in hypophysecto-mized rats. Acta Physiol Scand. 1982;114(2):261-265.
29. Clark RG, Robinson IC. Growth hormone responses to multiple injections of a fragment of human growth hormone-releasing factor in conscious male and female rats. J Endocrinol. 1985;106(3):281-289.
30. Isgaard J, Carlsson L, Isaksson OG, Jansson JO. Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion. Endocrinology. 1988;123(6):2605-2610.
31. Maiter D, Underwood LE, Maes M, Davenport ML, Ketelslegers JM. Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats. Endocrinology. 1988;123(2):1053-1059.
32. Steyn FJ, Xie TY, Huang L, et al. Increased adiposity and insulin correlates with the progressive suppressionofpulsatileGHsecretion during weight gain. J Endocrinol. 2013;218(2):233-244.
33. Hassouna R, Zizzari P, Tolle V. The ghrelin/obestatin balance inthe physiological and pathological control of growth hormone secretion, body composition and food intake. J Neuroendocrinol. 2010; 22(7):793-804.
34. Tolle V, Bassant MH, Zizzari P, et al. Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology. 2002;143(4):1353-1361.
35. Zizzari P, Longchamps R, Epelbaum J, Bluet-Pajot M-T. Obestatin partially affects ghrelin stimulation of food intake and growth hormone secretion in rodents. Endocrinology. 2007;148(4):1648-1653.
36. Hassouna R, Zizzari P, Viltart O, et al. A natural variant of obesta-tin, Q90L, inhibits ghrelin's action on food intake and GH secretion and targets NPY and GHRH neurons in mice. PLoS One. 2012; 7(12):e51135.
37. Gargantini E, Grande C, Trovato L, Ghigo E, Granata R. The role of obestatin in glucose and lipid metabolism. Horm Metab Res. 2013;45(13):1002-1008.
38. Delhanty PJ, Huisman M, Baldeon-Rojas LY, et al. Des-acyl ghrelin analogs prevent high-fat-diet-induced dysregulation of glucose ho-meostasis. FASEB J. 2013;27(4):1690-1700.
39. Asakawa A, Inui A, Fujimiya M, et al. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut. 2005;54(1): 18-24.
40. Pantel J, Legendre M, Cabrol S, et al. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest. 2006;116(3):760-768.
41. Holst B, Schwartz TW. Ghrelin receptor mutations-too little height and too much hunger. J Clin Invest. 2006;116(3):637-641.
42. Kern A, Albarran-Zeckler R, Walsh HE, Smith RG. Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron. 2012;73(2):317-332.
43. Cassoni P, Papotti M, Ghe C, et al. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab. 2001; 86(4):1738-1745.
44. Zhao T-J, Liang G, Li RL, et al. Ghrelin O-acyltransferase (GOAT) is essential for growth hormone-mediated survival of calorie-restricted mice. Proc Natl Acad Sci USA. 2010;107(16): 7467-7472.
45. Kirchner H, Gutierrez JA, Solenberg PJ, et al. GOAT links dietary lipids with the endocrine control of energy balance. Nat Med. 2009; 15(7):741-745.
46. Casanueva FF. Physiology of growth hormone secretion and action. Endocrinol Metab Clin North Am. 1992;21(3):483-517.
47. Moller N, Jorgensen JO, Alberti KG, Flyvbjerg A, Schmitz O. Short-term effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man. J Clin Endocrinol Metab. 1990; 70(4):1179-1186.
48. Horber FF, Haymond MW. Human growth hormone prevents the protein catabolic side effects of prednisone in humans. J Clin Invest. 1990;86(1):265-272.
49. Yi C-X, Heppner KM, Kirchner H, et al. The GOAT-ghrelin system is not essential for hypoglycemia prevention during prolonged calorie restriction. PLoS One. 2012;7(2):e32100.
50. Sonntag WE, Steger RW, Forman LJ, Meites J. Decreased pulsatile release of growth hormone in old male rats. Endocrinology. 1980; 107(6):1875-1879.
51. Wagner C, Caplan SR, Tannenbaum GS. Interactions of ghrelin signaling pathways with the GH neuroendocrine axis: a new and experimentally tested model. J Mol Endocrinol. 2009;43(3):105-119.
52. Holt RI. Fetal programming of the growth hormone-insulin-like growth factor axis. Trends Endocrinol Metab. 2002;13(9):392-397.
53. Harvey N, Cooper C. The developmental origins of osteoporotic fracture. J Br Menopause Soc. 2004;10(1):14-15, 29.